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Introduction {#embr201540946-sec-0001}
============

Located within the pancreas, the islets of Langerhans are composed of endocrine cells expressing glucagon (alpha cells), insulin (beta cells), somatostatin (delta cells), pancreatic polypeptide (PP cells), and ghrelin (epsilon cells). Furthermore, they are heavily vascularized and innervated, and in contact with the surrounding acinar and ductal cells of the exocrine pancreas. Pancreatic islets function as highly specialized micro‐organs that monitor and maintain blood glucose homeostasis. While damage to beta cells causes diabetes, the other pancreatic cell types may also contribute to pathogenesis in ways that are not well understood. Recent studies showed that both alpha [1](#embr201540946-bib-0001){ref-type="ref"} and delta cells [2](#embr201540946-bib-0002){ref-type="ref"} have the potential to replenish beta cell mass in animal models.

Development of diabetes correlates with global changes in the transcriptome of pancreatic islets [3](#embr201540946-bib-0003){ref-type="ref"}. These gene expression changes could reflect alterations in the cell subtype composition of the islet and/or changes in the transcriptomes of beta cells or other individual cell types. Analyzing islet cell‐specific gene expression changes has the potential to shed light on the etiology of diabetes. Recently, alpha and beta cell purification protocols from human [4](#embr201540946-bib-0004){ref-type="ref"}, [5](#embr201540946-bib-0005){ref-type="ref"}, [6](#embr201540946-bib-0006){ref-type="ref"} and mouse islets [7](#embr201540946-bib-0007){ref-type="ref"}, [8](#embr201540946-bib-0008){ref-type="ref"} have yielded initial maps of cell type‐specific transcriptomes. The available transcriptome datasets further comprise primary mouse and human alpha cells, beta cells, and delta cells, a number of rodent alpha and beta cell lines, and one human beta cell line [4](#embr201540946-bib-0004){ref-type="ref"}, [9](#embr201540946-bib-0009){ref-type="ref"}, [10](#embr201540946-bib-0010){ref-type="ref"}, [11](#embr201540946-bib-0011){ref-type="ref"}, [12](#embr201540946-bib-0012){ref-type="ref"}. Despite the rapid progress in this field, a comprehensive transcriptome database for individual human islet cell types is still missing, and no transcriptome data are currently available for PP cells.

Recent advances in next‐generation sequencing and library preparation enabled for the first time the transcriptome characterization of single cells from primary tissue. For example, this approach was successfully used to establish transcriptome profiles and dissect cell type heterogeneity for primary tissue obtained from the lung [13](#embr201540946-bib-0013){ref-type="ref"}, the spleen, and the brain [14](#embr201540946-bib-0014){ref-type="ref"}, [15](#embr201540946-bib-0015){ref-type="ref"}.

Here, we used single‐cell RNA‐seq to establish a comprehensive transcriptome database for the cell types that are present in primary human pancreatic islets. Principal component analysis in combination with visualization as biplots identified alpha cells, beta cells, delta cells, PP cells, acinar cells, and pancreatic duct cells directly from the single‐cell transcriptome profiles. We illustrate the utility of this resource by discovering novel cell type‐specific marker genes, and we identified human‐specific expression patterns in alpha and beta cells. All data are readily available for user‐friendly online browsing and download to foster research on pancreatic islet biology and diabetes‐related mechanisms in human.

Results and Discussion {#embr201540946-sec-0002}
======================

Single‐cell transcriptomes recapitulate pancreatic endocrine cell types {#embr201540946-sec-0003}
-----------------------------------------------------------------------

Primary human pancreatic islets of Langerhans were disassociated into single cells, and these cells were sorted into individual wells of a 96‐well plate by FACS [16](#embr201540946-bib-0016){ref-type="ref"}. The Smart‐Seq2 protocol [17](#embr201540946-bib-0017){ref-type="ref"} was then applied to obtain single‐cell transcriptomes. Following the generation and amplification of cDNA, we determined the levels of beta‐actin expression by qRT--PCR and selected all cell‐containing wells for library preparation and next‐generation sequencing (Fig [1](#embr201540946-fig-0001){ref-type="fig"}A). Seventy cells were sequenced in total, of which 64 cells passed quality control (see [Materials and Methods](#embr201540946-sec-0005){ref-type="sec"}) and were included in the analysis (Fig [EV1](#embr201540946-fig-0001ev){ref-type="fig"}A and B, and [Dataset EV1](#embr201540946-sup-0003){ref-type="supplementary-material"}). We obtained an average of 12.7 million high‐quality reads per single cell, of which 62.9% aligned to the human reference genome. RNA expression levels were calculated using the BitSeq software which uses RPKM normalization and corrects for non‐uniform read distribution along the transcripts (e.g., 3‐prime bias) [18](#embr201540946-bib-0018){ref-type="ref"}. Data quality was validated by assessing the relation between expression level and transcript length in native RNA (Fig [EV1](#embr201540946-fig-0001ev){ref-type="fig"}C) as well as ERCC spike‐in controls (Fig [EV1](#embr201540946-fig-0001ev){ref-type="fig"}D). While transcript length and expression level were not correlated in the ERCC spike‐in controls, we detected a negative correlation (*r* = −0.405) in the native RNA which was in the range of what had been previously reported as biologically significant finding [19](#embr201540946-bib-0019){ref-type="ref"}. However, a potential bias due to transcript length normalization cannot be completely excluded; therefore, comparing expression levels of different transcripts/genes should be performed with caution. To define global similarities among the single cells and the marker genes that drive these similarities, we performed principal component analysis (PCA) on the transcriptome dataset and displayed the results as biplots. PCA on the full dataset separates a group of 18 cells based on high *glucagon (GCG)* and *transthyretin (TTR)* expression and a group of 9 cells expressing *pancreatic polypeptide (PPY)* from a heterogeneous group of 37 cells (Fig [1](#embr201540946-fig-0001){ref-type="fig"}B). In a second PCA on the 37 yet undefined cells, we identified a group of 12 cells with high *insulin (INS)* expression, a group of 11 cells characterized by *PRSS2*,*CTRB2*,*REG3A*,*REG1A*, and *REG1B* and a group of two *somatostatin (SST)*‐expressing cells. In a third PCA on the remaining 12 undefined cells, a group of 8 cells was characterized by *keratin18 (KRT18)* and *keratin8 (KRT8)*. Based on the expression profiles of the identified marker genes, we were able to uniquely assign 60 out of 64 single‐cell transcriptomes to the alpha, beta, delta, PP, acinar, or ductal cell type (Fig [1](#embr201540946-fig-0001){ref-type="fig"}C).

![Single‐cell transcriptomes recapitulate the major pancreatic cell types\
Workflow for obtaining and analyzing single‐cell RNA‐seq data from human pancreatic islets.Iterative PCA/biplot‐based approach for the identification of cell types and cell type‐defining transcripts from single‐cell RNA‐seq data.Expression (scaled RPKM values) of cell type‐defining genes as identified in (B) across all single cells. Transcripts and single cells are grouped by cell type as identified in (B).Display of transcriptional similarity between all single cells by MDS. The coloring scheme is based on the cell types as identified in (B).Relative expression (scaled RPKM value) of canonical marker genes for the 6 identified pancreatic islet cell populations represented by bubble size and projected onto the MDS profile.](EMBR-17-178-g002){#embr201540946-fig-0001}

![Statistical analysis of single‐cell RNA‐seq data\
Number of detected transcripts and total aligned reads for each single cell. The red line denotes 500 transcripts, below which samples were excluded from the analysis.Scatter plots displaying the correlation between the number of input ERCC RNA molecules and measured RPKM values in four representative single cells. The Pearson correlation (*r*) is noted in the upper left corner.Scatter plots correlating raw read counts (left) and RPKM normalized expression values (right) with transcript length. All adequately covered transcripts (\> 25 reads) of all 64 samples were included in this analysis. The observed negative correlation after RPKM normalization lies in the range of what had been reported previously [19](#embr201540946-bib-0019){ref-type="ref"}.Raw counts and RPKM normalized expression values for 10 groups of ERCC spike‐in controls. The amount of molecules spiked into the sequencing reaction is constant within one group, whereas the length of the transcripts varies considerably. Within each group, equal expression values across different transcript lengths thereby confirm that RPKM normalization does not systematically penalize longer transcripts in the assessed ERCC transcript length range of ˜200 to 2,000 bp. ERCC spike‐in controls covered by more than 25 reads are indicated in blue and those with ≤ 25 reads in red.MDS displaying transcriptional similarity between corresponding cell types of a published dataset [20](#embr201540946-bib-0020){ref-type="ref"} (prefix: ext) and the current dataset.](EMBR-17-178-g003){#embr201540946-fig-0001ev}

As an additional validation of our cell type classification, we visualized the global transcriptional similarity of individual pancreatic cells by multidimensional scaling (MDS), where each single‐cell transcriptome was colored by the cell type derived from PCA (Fig [1](#embr201540946-fig-0001){ref-type="fig"}D). When mapped upon the MDS plot, the known cell type‐specific marker genes *INS*,*GCG*,*PPY*,*SST*,*REG1A,* and *KRT8* show the expected expression patterns, with different amounts of variability within the subgroups (Fig [1](#embr201540946-fig-0001){ref-type="fig"}E). The validity of our single‐cell RNA‐seq dataset was further confirmed in direct comparison to an external dataset consisting of bulk RNA‐seq data for whole islet, beta, and acinar cells [20](#embr201540946-bib-0020){ref-type="ref"}. Using MDS, we show high transcriptional similarity between the corresponding cell types of both datasets (Fig [EV1](#embr201540946-fig-0001ev){ref-type="fig"}E). The expression information of individual cells and merged expression values for each cell type is available in [Dataset EV2](#embr201540946-sup-0004){ref-type="supplementary-material"}.

To rule out technical reasons as a major source of gene expression variability, we identified presumably pure alpha and beta cells among the assessed single cells (Fig [EV2](#embr201540946-fig-0002ev){ref-type="fig"}A). Their transcription profiles were used to simulate transcriptomes with defined percentages of alpha and beta cell contribution (Fig [EV2](#embr201540946-fig-0002ev){ref-type="fig"}B). Individual alpha and beta cells were then compared to these virtual transcriptomes to estimate upper limits for potential cross‐contamination (Fig [EV2](#embr201540946-fig-0002ev){ref-type="fig"}C--E). All beta cell transcriptomes were found to be free from any alpha cell contribution, whereas beta cell profiles could explain a small proportion (\< 3%) of the variance observed in 8 of the 18 alpha cells studied. However, given that these alpha cells further show higher unexplained variance, it is likely that they are characterized by high inherent variability rather than cross‐contamination from beta cells. We conclude that the differences between alpha and beta cell heterogeneity are in line with biological rather than technical effects which supports the hypothesis that alpha cells might be more plastic than beta cells [4](#embr201540946-bib-0004){ref-type="ref"}.

![Assessing cross‐contamination between alpha and beta cells\
Scatter plot displaying single alpha and beta cells, 500‐cell islet samples, as well as bulk islet and beta cell samples from published datasets according to their weighted mean of scaled expression values in alpha and beta cell‐specific profile genes. The three selected profile cells for each cell type are indicated by their sample ID.Pure and mixed expression profiles consisting of 233 alpha cell‐specific genes and 252 beta cell‐specific genes. Alpha and beta cell‐specific profiles are calculated based on the expression values of the three selected profile cells only, while profile genes were selected based on all single cells classified as alpha or beta cells, which is why the expression gradients in the mix profiles do not always follow the same direction.Profile correlation curves for each individual sample. The maximum of each curve defines the maximum variance that can be explained (*y*‐axis) by the corresponding mix profile (*x*‐axis) providing a measure for the composition of the respective sample.Diagram explaining the transition from profile correlation curves to sample composition estimates. The profile composition that explains most variance is linearly scaled to the maximum variance explained.Sample composition estimates for each assessed sample. The differences between the 500‐cell islet samples and bulk samples might be explained by technical effects that enrich for alpha cells during islet cultivation, disassociation, and FACS purification.](EMBR-17-178-g005){#embr201540946-fig-0002ev}

The heterogeneity within the different cell types was further explored by separate PCAs for each cell type ([Appendix Fig S1](#embr201540946-sup-0001){ref-type="supplementary-material"}). Particularly for endocrine cells, heterogeneity was mainly driven by expression differences of marker genes as identified in the initial cell type classification by PCA, suggesting that these cell types are characterized by a spectrum of marker gene expression levels. While this analysis provides evidence for transcriptional heterogeneity, more cells are needed to thoroughly characterize subgroups within the different cell types.

A transcriptome resource to reveal marker genes of human pancreatic cell types {#embr201540946-sec-0004}
------------------------------------------------------------------------------

To maximize the utility of our dataset for the identification of cell type‐specific expression patterns, we generated a resource of genome browser tracks of all individual cells as well as cumulative tracks for the cell type clusters identified by PCA (<http://islet-transcriptome.computational-epigenetics.org/>). One interesting use of this resource is the analysis of master regulatory transcription factors, which are fundamental for the development and the maintenance of different pancreatic cell types based on animal models and human genetics. The genome browser tracks illustrate the beta cell‐specific expression of *PDX1*, a master regulatory transcription factor directly controlling insulin expression. In contrast, the alpha lineage‐defining factor *ARX* is expressed in both alpha and some PP cells (Fig [2](#embr201540946-fig-0002){ref-type="fig"}A and [Appendix Fig S2](#embr201540946-sup-0001){ref-type="supplementary-material"}). Other transcription factors that are important for pancreas development have different degrees of cell type‐specific expression in mature human islets, including pan‐endocrine (*PAX6*), beta cell‐specific (*PAX4*), and duct/delta (*HHEX*) patterns (Fig [2](#embr201540946-fig-0002){ref-type="fig"}B). While *MAFA* is transcribed in beta cells specifically, we observed robust *MAFB* expression in alpha, beta, and delta cells. Half of the beta cells studied expressed *MAFA* and *MAFB* concomitantly. In addition to these previously described factors, we also observed cell type‐specific expression for transcriptional regulators, which have not yet been extensively characterized in the endocrine pancreas. For example, *MORF4L1* shows a similar pan‐endocrine pattern to the canonical islet cell marker *NEUROD1* (Fig [2](#embr201540946-fig-0002){ref-type="fig"}C). A subset of alpha cells express *IRX2* (Fig [2](#embr201540946-fig-0002){ref-type="fig"}D), some beta cells show high expression of *polycomb ring finger oncogene (BMI1)* (Fig [2](#embr201540946-fig-0002){ref-type="fig"}E), and PP cells can be characterized by the transcription factors *ETV1* and *MEIS1* (Fig [2](#embr201540946-fig-0002){ref-type="fig"}F).

![Expression of cell type‐specific transcription factors at single‐cell resolution\
AMerged UCSC Genome Browser tracks for the *PDX1* and *ARX* loci. The respective tracks for all single cells are presented in [Appendix Fig S2](#embr201540946-sup-0001){ref-type="supplementary-material"}.BRelative expression (scaled RPKM value) of important transcription factors represented by bubble size and projected onto the MDS profile.C--FCell type‐specific expression of pan‐endocrine (C), alpha cell (D), beta cell (E), and PP cell (F) transcription factors (red bar: mean expression). The statistical significance of the differential gene expression is presented in [Appendix Fig S6](#embr201540946-sup-0001){ref-type="supplementary-material"}.](EMBR-17-178-g004){#embr201540946-fig-0002}

We further performed pairwise correlation analysis on transcript level to identify genes, of which the expression profiles correlate highly (*r* \> 0.9) with those of the endocrine marker genes *INS, GCG, SST,* and *PPY* (Fig [EV3](#embr201540946-fig-0003ev){ref-type="fig"}). While several highly correlated genes could be identified for *INS* and *SST* (e.g., zinc transporter *SLC39A4* and Notch pathway component *DLK1* for *INS* and transcription factors *NKX6‐3*,*ZNF430* for *SST*), the expression profiles of *GCG* and *PPY* did not show high correlation with any other genes.

![Assessing pairwise correlation of endocrine marker genes\
Correlation matrix displaying all genes (*y*‐axis) that are highly correlated (*r* \> 0.9) with at least one of the endocrine marker genes (*x*‐axis). Different transcripts of the same gene are indicated by "Tx".](EMBR-17-178-g007){#embr201540946-fig-0003ev}

To extend our analysis beyond transcription factors and known marker genes, we performed pairwise comparisons of cell type‐specific transcriptomes by gene set enrichment analysis ([Dataset EV3](#embr201540946-sup-0005){ref-type="supplementary-material"}). Interestingly, we observed strong enrichment of a gene set containing the REST‐binding motif in all endocrine cell types compared to acinar and ductal cells (Fig [3](#embr201540946-fig-0003){ref-type="fig"}A). Most genes that contain the REST motif in their promoters are expressed in alpha, beta, delta, and PP cells, whereas they are repressed in ductal and acinar cells (Fig [3](#embr201540946-fig-0003){ref-type="fig"}B). The transcriptional repressor REST targets the REST‐binding motif. In line with the target gene expression pattern, *REST* is specifically expressed in ductal and acinar cells (Fig [3](#embr201540946-fig-0003){ref-type="fig"}C and [Appendix Fig S3](#embr201540946-sup-0001){ref-type="supplementary-material"}).

![Single‐cell transcriptomes reveal unique features of human islets\
AHeatmap displaying the *P*‐values obtained by pairwise Gene Set Enrichment Analysis (GSEA) for the REST‐binding motif.BRelative expression (scaled RPKM value) of genes contained in the REST‐binding motif gene set.CMerged UCSC Genome Browser tracks for *REST*. The respective tracks for all single cells are presented in [Appendix Fig S3](#embr201540946-sup-0001){ref-type="supplementary-material"}.DExpression of DLK1 and GC in human islet cell types (red bar: mean expression). The statistical significance of the differential gene expression is presented in [Appendix Fig S6](#embr201540946-sup-0001){ref-type="supplementary-material"}.E--HCo‐staining of *DLK1* (E, F) or *GC* (G, H) with insulin and with glucagon in representative human (E, G) and mouse (F, H) islets.](EMBR-17-178-g006){#embr201540946-fig-0003}

Finally, based on pairwise differential expression analysis between the pancreatic cell types, genes with highly specific expression patterns were identified (Fig [EV4](#embr201540946-fig-0004ev){ref-type="fig"} and [Appendix Fig S4](#embr201540946-sup-0001){ref-type="supplementary-material"}, [Datasets EV4](#embr201540946-sup-0006){ref-type="supplementary-material"} and [EV5](#embr201540946-sup-0007){ref-type="supplementary-material"}). We then used these data to assess islet cell type‐specific expression in two areas of high relevance for diabetes research--diabetes risk genes and mouse--human species differences.

![Specific expression of selected marker genes\
Relative expression (scaled RPKM value) of interesting genes across all single cells represented by bubble size and projected onto the MDS profile as displayed in Fig [1](#embr201540946-fig-0001){ref-type="fig"}D.](EMBR-17-178-g008){#embr201540946-fig-0004ev}

Genomewide association studies (GWAS) have identified genomic loci conferring increased risk for the development of diabetes. We examined whether any of the diabetes‐related genes predicted by GWAS were specifically expressed in one of the pancreatic islet cell types and genes differentially expressed between the endocrine and exocrine cell types (Fig [EV5](#embr201540946-fig-0005ev){ref-type="fig"}A). For both type 1 and type 2 diabetes, we identified GWAS genes with beta cell‐ and endocrine‐specific expression. Other genes show broader expression patterns, emphasizing the complexity of functional annotation of diabetes GWAS results. Furthermore, key MODY (Mature Onset of Diabetes in Young) [21](#embr201540946-bib-0021){ref-type="ref"} genes *PDX1, PAX4, INS, HNF1A, GCK* are predominantly specific to beta cells (Fig [EV5](#embr201540946-fig-0005ev){ref-type="fig"}B).

![Assessing cell type specificity of genes identified in diabetes‐related GWAS\
Cell type specificity for genes reported in diabetes‐related GWAS. Each gene reported in a diabetes‐related GWAS (search for "Diabetes" on GWAS Catalog) was assigned to the pancreatic cell type in which it was found to be most specifically expressed. Ranking was performed as described in [Appendix Fig S7B](#embr201540946-sup-0001){ref-type="supplementary-material"} and [Dataset EV6](#embr201540946-sup-0008){ref-type="supplementary-material"}.Heatmap showing mean expression values for the most cell type‐specific diabetes‐associated GWAS genes in the different here identified human islet cell types. Specifically, only genes with a specificity rank lower than 500 (dashed line in panel A) are listed, and genes with equal expression in multiple cell types are not shown. The numbers in the colored boxes indicate the number of studies in which the respective gene has been reported. Heatmaps are colored by mean ln(RPKM), the mean of the natural logarithm of the RPKM values across all cells of the respective cell type.](EMBR-17-178-g009){#embr201540946-fig-0005ev}

To investigate species‐specific differences of alpha and beta cell transcriptomes, we assessed the degree to which the previously identified differentially expressed mouse genes [7](#embr201540946-bib-0007){ref-type="ref"}, [9](#embr201540946-bib-0009){ref-type="ref"} are also differentially expressed in human islets and vice versa ([Appendix Fig S5](#embr201540946-sup-0001){ref-type="supplementary-material"}). We found that the human alpha cell‐specific gene *group‐specific component (vitamin D binding protein) GC* and the human beta cell‐specific gene *DLK1* (Fig [3](#embr201540946-fig-0003){ref-type="fig"}D) displayed opposite expression patterns as to what had been reported in mouse islet cells. To confirm the cell type‐specific expression of *DLK1* and *GC*, we performed immunofluorescence staining on both human and mouse pancreatic tissue sections. In human islets, *DLK1* was specifically expressed only in insulin‐positive cells (Fig [3](#embr201540946-fig-0003){ref-type="fig"}E), whereas this protein was observed in glucagon‐positive cells in mouse tissue (Fig [3](#embr201540946-fig-0003){ref-type="fig"}F). Similarly, *GC* expression showed alpha cell specificity in human tissues (Fig [3](#embr201540946-fig-0003){ref-type="fig"}G), whereas it was co‐expressed with insulin in mouse tissues (Fig [3](#embr201540946-fig-0003){ref-type="fig"}H). These results suggest that two of the most differentially expressed cell type‐specific marker genes for human alpha and beta cells have opposite expression patterns in mouse islets.

Pancreatic islets comprise different cell types with characteristic transcriptomes, which confounds transcriptome studies that focus on whole pancreatic islets in physiological and pathological conditions. Lineage‐labeled transgenic mice have made it possible to obtain transcriptomes for highly pure alpha and beta cell populations in mouse. For human islets, however, cell type‐specific enrichment strategies depend on the availability of specific antibodies. Efforts have been made to measure the transcription of individual genes in single human islet cells by qRT--PCR [22](#embr201540946-bib-0022){ref-type="ref"}, but our dataset is the first to provide genomewide transcriptional information of human islets at single‐cell resolution. Using single‐cell data, we also for the first time defined the transcriptomes of human delta cells and PP cells, thereby providing reference transcriptomes for all major endocrine cell types in human pancreatic islets.

We illustrated the practical utility of our resource and dataset by three case studies. First, after confirming the cell type specificity of the major transcription factors involved in pancreatic endocrine lineage determination, we identified transcripts encoding transcription factors expressed in islet cells. These include the pan‐endocrine marker *MORF4L1*, alpha cell‐specific *IRX2*, beta cell‐specific *BMI1*, and PP cell‐specific *MEIS1* and *ETV1*. These data can provide the basis for future functional studies in the roles of these transcription factors in the pancreas and in diabetes.

In a second example, we analyzed cell type‐specific enrichment of previously characterized gene sets. The specific expression of REST‐motif‐containing genes in the endocrine cell types led us to identify the specific expression of the transcriptional repressor *REST* in the exocrine pancreas. REST recruits a large complex of chromatin regulators, including many factors that allow pharmacological modulation like histone deacetylases and the histone demethylase LSD1. REST repression in non‐endocrine cells activates the promoters of important beta cell transcription factors, including PAX4 and PDX1 and is a key step in reprogramming to insulin‐producing cells [23](#embr201540946-bib-0023){ref-type="ref"}, [24](#embr201540946-bib-0024){ref-type="ref"}, [25](#embr201540946-bib-0025){ref-type="ref"}, [26](#embr201540946-bib-0026){ref-type="ref"}. Future studies will show whether REST is critical in restricting ductal differentiation potential and may be a target for inducing beta cell neogenesis from duct cells.

Finally, in a third example, we focused on differences between mouse and human islets. Previous studies have noticed such differences regarding the overall architecture and specific physiological properties [7](#embr201540946-bib-0007){ref-type="ref"}, [27](#embr201540946-bib-0027){ref-type="ref"}. Our human islet single‐cell transcriptomes confirm that the expression of hormones and canonical transcription factors is conserved between human and mouse. However, two genes---*GC* and *DLK1*---that are among the most characteristic for human alpha and beta cells, respectively, are expressed in opposite patterns in the mouse. Both *DLK1* and *GC* are relevant to diabetes [5](#embr201540946-bib-0005){ref-type="ref"}, [28](#embr201540946-bib-0028){ref-type="ref"}, and further research is necessary to dissect their roles in both human and mouse islet biology.

These examples highlight the utility of the current single‐cell transcriptome database for islet biology. In addition, we expect future growth of our resource with the addition of single‐cell expression data from diabetic donors and from islets treated with drugs and metabolites *ex vivo*, contributing to the utility of the presented resource for studies on all aspects of human islet biology. In summary, our study establishes a transcriptional dataset for all the cell types in human pancreatic islets with single‐cell resolution and defines distinctly human features in the patterns of alpha and beta cell‐expressed genes.

Materials and Methods {#embr201540946-sec-0005}
=====================

Reagents {#embr201540946-sec-0006}
--------

Antibodies used in this project are directed against insulin (Sigma I8510), glucagon (Abcam ab92517), DLK1 (R&D MAB1144‐100), and GC (Abcam ab81307). The sequences of primers for actin have been published recently [29](#embr201540946-bib-0029){ref-type="ref"}. All the fluorescently labeled secondary antibodies were purchased from Life Technologies Corporation. The reagents used for the Smart‐seq2 protocol for cDNA synthesis, amplification, and sequencing library preparation have been published recently [17](#embr201540946-bib-0017){ref-type="ref"}.

Cell culture {#embr201540946-sec-0007}
------------

Human islets were provided through the JDRF award 31‐2012‐783 (ECIT: Islet for Research program). They were from a 37‐year‐old male donor whose BMI was 22. Islets were cultured in CMRL medium (Life Technologies) supplemented with 10% FBS, 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. Islets were collected following overnight culture after receiving them. To disassociate islets into single cells, islets were incubated in Accutase (Life Technologies) in 37°C for 20 min, neutralized by CMRL medium. Purification of single cells was performed by flow cytometry cell sorting on a Moflo AstriosEQ (Beckman Coulter, Miami) as previously described in [16](#embr201540946-bib-0016){ref-type="ref"}.

Immunofluorescence {#embr201540946-sec-0008}
------------------

The human pancreatic histology slides were ordered from Abcam (ab4611). The mouse pancreatic histology slides from 129SV mice were gifts from Patrick Collombat. The staining followed a published protocol [30](#embr201540946-bib-0030){ref-type="ref"}. Briefly, the paraffin was removed from the tissues. Afterwards, rehydration and antigen retrieval was performed. The tissues were blocked by 3% BSA for half an hour and incubated overnight at 4°C with primary antibodies in 1:1,000 dilutions. After washing with PBST, tissues were incubated with secondary antibodies and Hoechst 33342 for half an hour. Finally, the slides were mounted and sealed with nail polish and images were taken with Leica CRT6000.

Single‐cell RNA‐seq sample and sequencing library preparation {#embr201540946-sec-0009}
-------------------------------------------------------------

cDNA synthesis and enrichment were performed following the Smart‐seq2 protocol as described Picelli *et al* [17](#embr201540946-bib-0017){ref-type="ref"}. ERCC spike‐in RNA (Ambion) was added to the lysis buffer in a dilution of 1:1,000,000. Library preparation was conducted on 1 ng of cDNA using the Nextera XT library preparation kit (Illumina) as described Picelli *et al* [17](#embr201540946-bib-0017){ref-type="ref"}. Sequencing was performed by the Biomedical Sequencing Facility at CeMM using the 50 bp single‐read setup on the Illumina HiSeq 2000/2500 platform.

qRT--PCR {#embr201540946-sec-0010}
--------

After the cDNA was synthesized and amplified from single cells, quantitative PCR was performed with Power SYBR Green PCR Master Mix (Applied Biosystems) on a LightCycler 480 qPCR instrument (Roche).

Single‐cell RNA‐seq data processing {#embr201540946-sec-0011}
-----------------------------------

The raw sequencing data were processed using a custom bioinformatics pipeline which consists of the following main steps: (i) trimming of contaminating sequencing adapter sequences, (ii) alignment of the trimmed reads to the human transcriptome as well as genome, (iii) calculation of expression estimates for each transcript, differential expression analysis and visualization as genome browser tracks.

Trimming of adapter sequences was performed with trimmomatic (v 0.32). Only reads with a minimum length of 25 bp after adapter trimming were included in the downstream analysis. Alignment of the trimmed reads to the human transcriptome (hg19 GRCh37 <ftp://ftp.ensembl.org/pub/release-74/fasta/homo_sapiens/cdna/Homo_sapiens.GRCh37.74.cdna.all.fa.gz>) was performed with bowtie1 (v 1.1) [31](#embr201540946-bib-0031){ref-type="ref"} recording up to 100 different mapping positions for each read which takes into account that one read might originate from any of the different transcripts of one gene. Alignment to the human genome (hg19/GRCh37) was performed using Tophat (v 2.0.13) [32](#embr201540946-bib-0032){ref-type="ref"}. These genomic alignments were purely performed for the purpose of visualization in genome browser tracks. Conversion of the alignment files to the files needed to display the data as genome browser tracks (bigWig) was performed with RSeQC (v 2.3.9) bam2wig.py followed by UCSC tools\' wigToBigWig. Calculation of normalized transcript‐wise expression estimates (rpkm values) as well as differential expression analysis was performed based on the transcriptome alignments using the R (v 3.1.2) package BitSeq (v 1.10.0) [18](#embr201540946-bib-0018){ref-type="ref"}. In order to correct for potential biases in the read distribution, the BitSeq function getExpression() was run with the "uniform" option disabled.

Quality filtering {#embr201540946-sec-0012}
-----------------

The minimal number of reads needed to obtain reliable RPKM values as estimates of gene expression was determined by taking advantage of a synthetic RNA mix consisting of 92 RNAs covering a 10^6^‐fold concentration range (ERCC spike‐in controls) that had been carried along through the entire library preparation and sequencing process with each single cell. Starting from \~25 reads per transcript, we observed the expected linear relationship between ERCC transcript abundance and measured RPKM values (Fig [EV1](#embr201540946-fig-0001ev){ref-type="fig"}B). For the purpose of noise reduction, we defined transcripts covered by less than 25 reads as "not expressed" and set their RPKM values to a minimal value. Furthermore, 6 samples showed less than 500 (arbitrary cutoff) reliably covered transcripts and were excluded from the analysis (Fig [EV1](#embr201540946-fig-0001ev){ref-type="fig"}A).

Grouping the single cells based on their gene expression profiles {#embr201540946-sec-0013}
-----------------------------------------------------------------

In order to determine groups of cells with similar expression profiles and at the same time identify the primary defining genes for each group, we performed a stepwise principal component analysis (PCA) based on the quality‐filtered expression values. PCA was performed using the function prcomp() in R. The results were displayed as a biplots showing samples (cells) as dots and the most highly loaded variables (transcripts) as vectors. Biplots were constructed using a slightly modified version of the R function ggbiplot() (<https://github.com/vqv/ggbiplot>).

External data {#embr201540946-sec-0014}
-------------

External RNA‐seq raw data (next‐generation sequencing reads) for bulk samples of human acinar cells, beta cells, and islet cells were obtained from ArrayExpress (E‐MTAB‐1294: <https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1294/samples/>) [20](#embr201540946-bib-0020){ref-type="ref"}. We used the samples HI10 (islet), HI25 (islet), HI32 (islet), HIE1 (beta cells), HIE2 (beta cells), and acinar tissue donor (acinar cells). External data were processed using the same pipeline as the single‐cell data. For the comparison of external and single‐cell as well as 500 cell data by multidimensional scaling, batch effect correction was performed using the function ComBat() of the R package sva.

Defining cell type‐specific gene expression profiles {#embr201540946-sec-0015}
----------------------------------------------------

Cell type‐specific gene expression profiles were defined by performing pairwise differential expression analysis between all previously defined groups of cells. Differential expression analysis was performed using the function estimateDE() of the R package BitSeq. For each cell type in each comparison, the specificity of the expression of each transcript was deduced under consideration of effect size (absolute difference and log2 fold change) as well as statistical significance (probability of positive log ratio, PPLR) of the measured differential expression. Technically, for each comparison, all transcripts were ranked by absolute difference in gene expression, log fold change of gene expression, and probability of positive log ratio and a combined rank for each transcripts was produced by selecting the worst (i.e., highest) of these three ranks as a representative rank. Finally, the representative ranks from all comparisons for each cell type were again combined by selecting the worst rank for each transcript ([Appendix Fig S7](#embr201540946-sup-0001){ref-type="supplementary-material"}). Therefore, the lower the combined rank, the more specific the expression of the respective transcript for the assessed cell type. To identify the cell type for which the expression of a given gene is most specific, we compared the assigned combined ranks between all cell types and selected the cell type that showed the lowest combined rank for this gene.

Assessing cross‐contamination between cell types {#embr201540946-sec-0016}
------------------------------------------------

We assessed potential cross‐contamination between two cell types using a four‐step approach: (i) selection of cell type‐specific genes (profile genes), (ii) selection of the purest single cells for each cell type (profile cells), (iii) calculation of pure and increasingly contaminated gene expression profiles *in silico* (mix profiles), and (iv) identification of the mix profiles that best match the expression profile of each single cell.

As profile genes, we selected all genes among the top 500 cell type‐specific genes for each of the two cell types that showed an absolute mean expression difference of greater than 0.5 and a relative mean expression difference of at least twofold. This selection resulted in 233 profile genes for alpha cells and 252 profile genes for beta cells.

To identify the purest cells of each cell type, we calculated a weighted mean of scaled expression values (sample‐wise, scale 0 to 1; lower percentile: 0.05, upper percentile: 0.95) for both groups of profile genes for each single cell (profile scores). We used a rank‐based weighting system in order to give more power to more cell type‐specific profile genes. All single cells were then plotted according to their profile scores, and per cell type, the three cells with the most cell type‐specific profile scores (highest distance to the diagonal) were selected as profile cells (Fig [EV2](#embr201540946-fig-0002ev){ref-type="fig"}A).

Pure expression profiles consisting of both groups of profile genes were calculated as the mean expression values of the three profile cells. We then used these two cell type‐specific profiles to artificially construct expression profiles that represented different degrees of contamination by computationally mixing the two profiles in different ratios. Specifically, we calculated weighted means of the two pure expression values for each profile gene, with the weight increasing from 0 to 100 in steps of 1 for one of the pure profiles and at the same time decreasing from 100 to 0 for the other pure profile. This resulted in 100 profiles, two pure (cell type specific) and 98 mixed profiles (Fig [EV2](#embr201540946-fig-0002ev){ref-type="fig"}B).

We then calculated the Pearson correlation of each of the artificial 100 profiles with the actual expression profiles of each of the single cells (Fig [EV2](#embr201540946-fig-0002ev){ref-type="fig"}C) and selected the highest correlating mix profile for each single cell. These selected mix profiles represent the fraction of variance in profile gene expression that is explained by either of the two cell type‐specific profiles as well as the fraction of variance that remains unexplained (Fig [EV2](#embr201540946-fig-0002ev){ref-type="fig"}D and E).

Gene set enrichment analysis {#embr201540946-sec-0017}
----------------------------

Binding motif analysis was done with Gene Set Enrichment Analysis (GSEA) [33](#embr201540946-bib-0033){ref-type="ref"}, [34](#embr201540946-bib-0034){ref-type="ref"}. For each single cell, the most highly expressed transcript was selected as representative for the respective gene. Finally, gene expression values for each cell type were found by calculating the median across all cells of a particular cell type. These median expression values were used as input for GSEA. Genes that were not found to be expressed in any of the cell types were removed from the input dataset. Pairwise comparisons were done among all six assigned cell types except the "undefined" amounting to 30 comparisons in total. The REST‐binding motif was significantly enriched (*P* \< 0.05, FDR \< 25%) in all of the comparisons between endocrine cell types and exocrine cell types.

GWAS analysis {#embr201540946-sec-0018}
-------------

GWAS results relevant for diabetes (search for "diabetes") were downloaded from the GWAS catalog (<https://www.ebi.ac.uk/gwas/>). We categorized the reported traits into type 1 and type 2 diabetes according to whether "1" or "2" appeared in the trait description. Each gene that was identified as significant in a GWAS (reported gene) was assigned to the cell type for which it was identified as most specific (see "[Defining cell type‐specific gene expression profiles](#embr201540946-sec-0015){ref-type="sec"}"). Because in this analysis specificity among the endocrine cells (alpha cells, beta cells, delta cells, PP cells) and among the exocrine cells (acinar cells, duct cells) was not paramount, cell type specificity was determined only in comparison with cell types of the other group. This approach was chosen in order to not dismiss genes as unspecific if they are endocrine or exocrine specific but not necessarily cell type specific. The eight MODY genes were taken from [21](#embr201540946-bib-0021){ref-type="ref"}.

Data deposition {#embr201540946-sec-0019}
---------------

Sequencing datasets described in this work have been deposited in the Gene Expression Omnibus (GEO) repository under accession number GSE73727.
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